POST FORUM SITE
PRESENTERS
ATTENDEES
​​INVESTORS & ANALYSTS
SUPPORTERS

confirmed attending companies include:

203 Investment Partners, LLC
60 Degrees Pharmaceuticals, LLC
A C Binder Corp.
AbbVie, Inc.
Abingworth LLP
AcuraStem, Inc.
Advanced Proteome Therapeutics Corp.
Aegis Capital Corp.
Aisling Capital, LLC
Aleta Biotherapeutics
Alex. Brown
Alpha Bronze
Alpine Equity Advisors
Amarantus BioScience Holdings, Inc.
apceth Biopharma GmbH
Arcus Ventures
ASDERA
AZTherapies, Inc.
Bigger Capital, LLC
Bioqube Ventures
Biosceptre International Limited
BioSeed Capital
BioSense Global, LLC
Biotech Alliances International, Inc.
Bishop Capital Management
Bloomberg Intelligence
Bradley Woods & Co.
Bristol-Myers Squibb
Brookline Capital Markets
C-Bridge Capital
Canaccord Genuity, Inc.
Cancer Research Institute
Cantex Pharmaceuticals, Inc.
Capital IP
CBT Advisors
Cellectis
Clinical Network Services (CNS) USA, Inc.
Crown Point Group
CTI Life Sciences
Cue Biopharma, Inc.
Dabar Investment Associates
Daiichi Sankyo Group
Deca Ventures
Defined Health, a Cello Health business
Double U Fund
Edison Group
Emerald Health Pharmaceuticals, Inc.
Enso Ventures
EpiVax Oncology
ESC Advisors
Excellentia Global Partners
Excelyrate Capital
F.B. Asset Management
Fortress Biotech
FreeMind Group
GC Finance
Gershon MedTech
GlaxoSmithKline PLC
Goodwin Procter LLP
Hemispherx Biopharma, Inc.
Image Analysis Group
ImmunoBiochem
Innovus Pharmaceuticals, Inc.
Inthera Bioscience AG
JDRF T1D Fund
Jefferies, LLC
JMP Securities, LLC
Johnson & Johnson Innovation Center-Boston
L2 Capital, LLC
Landmark Angels, Inc.

LB Pharmaceuticals, Inc.
Life Sciences Research International BV
LifeTech Capital
Little Gem Life Sciences
Locust Walk
Loop Capital  Markets
LSP
Manhattan BioSolutions, Inc.
MaxCyte, Inc.
Maxim Merchant Capital
Medivate Partners
MedPro Investors, LLC
Mergermarket
Mid Atlantic Bio Angels
Mizuho Bank
Morgan Stanley
MRL Ventures Fund
Murdock Capital Partners
NEA
NEMUS Bioscience, Inc.
New York Ventures
Nouscom AG
Novartis Venture Fund
Oberland Capital
OCT
Opto Capital Group
Oxford Bioscience Partners
Oxford Finance, LLC
Paulson Investment Company
Pfizer, Inc.
PJT Partners
Prevail Partners 
ProMIS™ Neurosciences, Inc.
PsiOxus Therapeutics Ltd.
Raymond James Financial, Inc.
Real Endpoints
Remiges Ventures
Roche Innovation Centre
Roosevelt Investments
RW Pressprich
Sachs Forum
Seaport Global Securities, LLC
Seva Venture Capital
Sevengenes, Inc. 
Shadow Lake Group Inc
Slater Technology Fund
Stalicla SA
Stanphyl Capital
SternAegis Ventures
Sternberg Investments
Syzygy Therapeutics
TapImmune, Inc.
TargImmune Therapeutics AG
The Astrologers Fund, Inc.
Tiberend Strategic Advisors, Inc.
Tilray
TransPacific Venture Capital Partners
Two Sigma Ventures
UCLA Technology Development Group
Valor Management S.A.
Varana Capital
Vitality Biopharma, Inc.
VLP Therapeutics
W Global Capital Limited
WBB Asset Management, LLC
WBB Securities, LLC
Windeye Partners
Wotczak Group
Zacks Investment Research, Inc.